CaryHealth Co-Founder and CEO Areo Nazari was featured in the Washington DC Economic Partnership's latest Executive Insights interview, highlighting CaryHealth's evolution from a direct-to-consumer digital pharmacy into a comprehensive health intelligence platform that's transforming healthcare delivery.
The spotlight interview showcases how CaryHealth's AI-powered suite of products—including CaryRx, OneDash, Clair, and CaryConnect—supports the complete healthcare ecosystem, from medication fulfillment to real-time clinical decision-making. Nazari discussed the company's mission to make healthcare more personal, proactive, and efficient for both patients and providers.
The feature emphasizes CaryHealth's remarkable growth trajectory and industry recognition. In 2025, Inc. Magazine named the company the #1 fastest-growing private company in the Mid-Atlantic region, noting over 3,000% revenue growth in just two years. CaryHealth also secured a position in the Top 100 on the 2024 Inc. 5000 national list and has been recognized as the #2 AI company in healthcare and the #1 fastest-growing company in Washington, DC.
Founded in 2017 and based in the District, CaryHealth exemplifies how Washington, DC's unique ecosystem of policy capital, research institutions, and civic-minded business community creates an ideal environment for scaling innovative health technology companies with meaningful impact.
The interview provides insights into how CaryHealth's tools help patients maintain treatment adherence while equipping care teams with critical data for early and effective interventions.
